The process of manufacturing viral vector and whole virus vaccines presents a challenge to President Joe Biden’s plans to ramp up production by waiving patent protections for COVID-19 vaccines.

Biden floated the idea last Wednesday, angering pharmaceutical companies in the process. Supporters of the proposal believe it would remove a major obstacle to letting the developing world manufacture generic versions of vaccines.